Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

180 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Reexamining treatment of high-grade T1 bladder cancer according to depth of lamina propria invasion: a prospective trial of 200 patients.
Orsola A, Werner L, de Torres I, Martin-Doyle W, Raventos CX, Lozano F, Mullane SA, Leow JJ, Barletta JA, Bellmunt J, Morote J. Orsola A, et al. Among authors: de torres i. Br J Cancer. 2015 Feb 3;112(3):468-74. doi: 10.1038/bjc.2014.633. Epub 2014 Dec 23. Br J Cancer. 2015. PMID: 25535728 Free PMC article. Clinical Trial.
[Glycoprotein P and resistance to antitumor chemotherapy].
Vicente P, Bellmunt J, de Torres I. Vicente P, et al. Among authors: de torres i. Med Clin (Barc). 1993 Dec 11;101(20):785-8. Med Clin (Barc). 1993. PMID: 7906748 Review. Spanish. No abstract available.
Early results of the value of p53 in predicting survival in a homogeneous cohort of patients with invasive bladder cancer treated with a neoadjuvant carboplatin-based regimen (M-CAVI).
Ribas A, Bellmunt J, Albanell J, De Torres I, Bermejo B, De Torres JA, Morote J, Gallardo E, Vera R, Carulla J, Sole-Calvo LA. Ribas A, et al. Among authors: de torres i, de torres ja. Tumori. 1996 Nov-Dec;82(6):554-9. doi: 10.1177/030089169608200608. Tumori. 1996. PMID: 9061063
Measurement of free PSA in the diagnosis and staging of prostate cancer.
Morote J, Raventós CX, Lorente JA, Lopez-Pacios MA, Encabo G, de Torres I, Andreu J. Morote J, et al. Among authors: de torres i. Int J Cancer. 1997 May 29;71(5):756-9. doi: 10.1002/(sici)1097-0215(19970529)71:5<756::aid-ijc11>3.0.co;2-6. Int J Cancer. 1997. PMID: 9180142
Comparison of percent free prostate specific antigen and prostate specific antigen density as methods to enhance prostate specific antigen specificity in early prostate cancer detection in men with normal rectal examination and prostate specific antigen between 4.1 and 10 ng./ml.
Morote J, Raventós CX, Lorente JA, Lopez-Pacios MA, Encabo G, de Torres I, Andreu J. Morote J, et al. Among authors: de torres i. J Urol. 1997 Aug;158(2):502-4. J Urol. 1997. PMID: 9224333
Androgen-independent basal cell re-epithelialization, c-erbB-2 mRNA expression and androgen-dependent EGFr mRNA expression in benign prostatic hyperplasia explant cultures treated with finasteride.
Schwartz S Jr, Caceres C, De Torres I, Morote J, Rodriguez-Vallejo JM, Gonzalez J, Reventos J. Schwartz S Jr, et al. Among authors: de torres i. Int J Cancer. 1998 May 18;76(4):519-22. doi: 10.1002/(sici)1097-0215(19980518)76:4<519::aid-ijc13>3.0.co;2-2. Int J Cancer. 1998. PMID: 9590128
180 results